CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates
SUZHOU, China, March 27, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research,
Stay updated with breaking news from 3sbio Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SUZHOU, China, March 27, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research,
/PRNewswire/ -- The "Biosimilar Monoclonal Antibodies Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The expansion of the...
3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totalling 574,000 shares, a growth of 57,300.0% from the December 15th total of 1,000 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is […]
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The
SUZHOU, China, Nov. 1, 2023 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research,